Episode 65 - CVS Health's Approach to Biosimilars and Formulary Strategy and What it Means for Plan Sponsors episode artwork

EPISODE · Aug 24, 2026 · 34 MIN

Episode 65 - CVS Health's Approach to Biosimilars and Formulary Strategy and What it Means for Plan Sponsors

from HR Benecast

Mike sits down with CVS Health's Josh Fredell, senior vice president, PBM payor and life science solution, to discuss how one of the most well-known names in the pharmacy industry approaches biosimilars, formulary strategy and clinical management. Watch or listen to Benefits Bites and Healthcare Headlines.  Register for upcoming Employers Health webinars or watch on demand at Events - Employers Health. Sign up for our monthly newsletter here. Find additional helpful benefits strategies and resources at Articles | Employers Health.

Episode metadata supplied by the publisher feed · Published Aug 24, 2026

Embed this episode

Ready to play

Episode 65 - CVS Health's Approach to Biosimilars and Formulary Strategy and What it Means for Plan Sponsors

0:00 34:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HR Benecast?

This episode is 34 minutes long.

When was this HR Benecast episode published?

This episode was published on August 24, 2026.

Can I download this HR Benecast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!